Corbus Pharmaceuticals Holdings (CRBP) EBITDA (2013 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly EBITDA came in at -$24.4 million in Q3 2025, down 57.48% year-on-year from -$57.4 million in Q3 2024, and down 1958.22% quarter-over-quarter from $1.3 million in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) EBITDA (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' EBITDA history runs 13 years deep, the most recent figure standing at -$24.4 million for Q3 2025.
- On a quarterly basis, EBITDA fell 57.48% year-over-year to -$24.4 million in Q3 2025; TTM through Sep 2025 was -$19.6 million, a 44.78% increase from a year earlier, with the FY2024 full-year figure at $6.3 million, up 114.0% from the prior year.
- EBITDA slipped to -$24.4 million in Q3 2025 per CRBP's latest filing, from $1.3 million in the prior quarter.
- Across five years, EBITDA topped out at $1.8 million in Q4 2024 and bottomed at -$24.4 million in Q3 2025.
- The 5-year median for EBITDA is -$10.1 million (2023), against an average of -$9.8 million.
- Across the five-year window, EBITDA slumped 103.08% in 2023 and surged 117.62% in 2024, its largest moves.
- Year by year, EBITDA stood at -$10.0 million in 2021, then retreated by 7.99% to -$10.8 million in 2022, then gained by 6.42% to -$10.1 million in 2023, then surged by 117.62% to $1.8 million in 2024, then plunged by 1471.74% to -$24.4 million in 2025.
- Per Business Quant, the three latest CRBP EBITDA figures stand at -$24.4 million (Q3 2025), $1.3 million (Q2 2025), and $1.7 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -24.42 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | -15.51 Mn |
| Jun 30, 2024 | -10.99 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | -10.10 Mn |
| Sep 30, 2023 | -9.49 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Mar 31, 2023 | -17.30 Mn |
| Dec 31, 2022 | -10.80 Mn |
| Sep 30, 2022 | -8.18 Mn |
| Jun 30, 2022 | -12.34 Mn |
| Mar 31, 2022 | -8.52 Mn |
| Dec 31, 2021 | -10.00 Mn |
| Sep 30, 2021 | -13.88 Mn |
| Jun 30, 2021 | -16.70 Mn |
| Mar 31, 2021 | -15.41 Mn |
| Dec 31, 2020 | -20.81 Mn |